Type of substance use and access to HIV-related health care

AIDS Patient Care and STDs

Volumn 20, Issue 6, 2006, Pages 399-407

  Cunningham, Chinazo O ^a   Sohler, Nancy L ^a,b   Berg, Karina M ^a   Shapiro, Scott ^c   Heller, Daliah ^d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

^d CitiWide Harm Reduction Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

AFRICAN AMERICAN; ALCOHOL CONSUMPTION; ARTICLE; COCAINE DEPENDENCE; DEMOGRAPHY; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; RACE DIFFERENCE; SEX DIFFERENCE; SUBSTANCE ABUSE; UNITED STATES;

ADULT; ALCOHOLISM; COCAINE; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEROIN; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; SUBSTANCE-RELATED DISORDERS;

EID: 33745611573     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2006.20.399     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2003, Vol. 15, Atlanta: U.S. Dept. of Health and Human Services, CDC, 2004, pp 1-46. www.cdc.gov/hiv/stats/hasrlink.htm Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention.
2. Chitwood DD, McBride DC, French MT, Comerford M. Health care need and utilization: A preliminary comparison of injection drug users, other illicit drug users, and nonusers. Subst Use Misuse 1999;34:727-746.
3. Turner BJ, Fleishman JA, Wenger N, et al. Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. J Gen Intern Med 2001;16:625-633.
4. Celentano DD, Vlahov D, Cohri S, Shadle VM, Obasanjo O, Moore RD. Self-reported antiretroviral therapy in injection drug users. JAMA 1998;280:544-546.
5. Kalichman SC, Graham J, Luke W, Austin J. Perceptions of health care among persons living with HIV/AIDS who are not receiving antiretroviral medications. AIDS Patient Care STDs 2002;16:233-240.
6. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study. JAMA 1999;281:2305-2315.
7. Strathdee SA, Palepu A, Cornelisse PG, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA 1998;280:547-549.
8. Cohen MH, Cook JA, Grey D, et al. Medically eligible women who do not use HAART: The importance of abuse, drug use, and race. Am J Public Health 2004;94:1147-1151.
9. Pulvirenti JJ, Glowacki R, Muppiddi U, et al. Hospitalized HIV-infected patients in the HAART era: A view from the inner city. AIDS Patient Care STDs 2003;17:565-573.
10. Arnsten JH, Demas PA, Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 2002;17:377-381.
11. Bouhnik AD, Chesney M, Carrieri P, et al. Nonadherence among HIV-infected injecting drug users: The impact of social instability. J Acquir Immune Defic Syndr 2002;31(Suppl 3):S149-S153.
12. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis 2000;30(Suppl 2):S171-S176.
13. Golin CE, Liu H, Hays RD, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med 2002;17:756-765.
14. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Ann Intern Med 1999;131:81-87.
15. Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med 2003;114:573-580.
16. Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS 2002;16:767-774.
17. Selwyn PA, Hartel D, Wasserman W, Drucker E. Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am J Public Health 1989;79:1358-1362.
18. Kohli R, Lo Y, Howard AA, et al. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy. Clin Infect Dis 2005;41:864-872.
19. Metsch LR, Pereyra M, Brewer TH. Use of HIV health care in HIV-seropositive crack cocaine smokers and other active drug users. J Subst Abuse 2001;13:155-167.
20. Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med 2004;19:1111-1117.
21. Sharpe TT, Lee LM, Nakashima AK, Elam-Evans LD, Fleming PL. Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women. J Community Health 2004;29:117-127.
22. Ingersoll K. The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care 2004;16:199-211.
23. Cejtin HE, Komaroff E, Massad LS, Korn A, Schmidt JB, Eisenberger-Matiyahu D et al. Adherence to colposcopy among women with HIV infection. J Acquir Immune Defic Syndr 1999;22:247-252.
24. Palacio H, Shiboski CH, Yelin EH, Hessol NA, Greenblatt RM. Access to and utilization of primary care services among HIV-infected women. J Acquir Immune Defic Syndr 1999;21:293-300.
25. Metsch LR, McCoy HV, McCoy CB, Miles CC, Edlin BR, Pereyra M. Use of health care services by women who use crack cocaine. Women Health 1999;30:35-51.
26. Cronquist A, Edwards V, Galea S, Latka M, Vlahov D. Health care utilization among young adult injection drug users in Harlem, New York. J Subst Abuse 2001;13:17-27.
27. Palepu A, Strathdee SA, Hogg RS, et al. The social determinants of emergency department and hospital use by injection drug users in Canada. J Urban Health 1999;76:409-418.
28. Cunningham CO, Shapiro S, Berg KM, Sacajiu G, Paccione G, Goulet JL. An evaluation of a medical outreach program targeting unstably housed HIV-infected individuals. J Health Care Poor Underserved 2005;16:127-138.
29. Swenson SL, Shapiro S, Cunningham C, Gourevitch MN. Health care needs assessment and predictors of HIV therapy use among HIV-infected residents of single room occupancy (SRO) hotels in the South Bronx. Society of General Internal Medicine National Conference, Boston, MA: 2000.
30. Chitwood DD, Sanchez J, Comerford M, McCoy CB. Primary preventive health care among injection drug users, other sustained drug users, and non-users. Subst Use Misuse 2001;36:807-824.
31. Cook RL, Sereika SM, Hunt SC, Woodward WC, Erlen JA, Conigliaro J. Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med 2001;16:83-88.
32. Kapadia F, Cook JA, Cohen MH, et al. The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use. Addiction 2005;100:990-1002.
33. Knowlton AK, Hoover DR, Chung SE, Celentano DD, Vlahov D, Latkin CA. Access to medical care and service utilization among injection drug users with HIV/AIDS. Drug Alcohol Depend 2001;64:55-62.
34. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000;12:255-266.
35. Halkitis PN, Parsons JT, Wolitski RJ, Remien RH. Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men. AIDS Care. 2003;15:89-102.